Event info
Date:27 Feb
Time:08:30 to 13:00
Venue:

Boost Seminar – Compound De-risking

Organotypic 3D-cell-culture systems are implemented at various stages in the compound development process for de-risking new drug candidates and can provide a wealth of meaningful efficacy and toxicology data. A growing list of publications confirms the striking similarities of these systems to in vivo tissue, clearly underlining their high potential value to the pharmaceutical industry.
This workshop offers you an excellent way to get fully updated with the latest information on 3D-cell-culture technologies for toxicological and efficacy studies. Our expert team and invited guest speakers from SIRION BIOTECH GmbH, with their many years of combined experience, are in an unique position to provide you with information on different approaches to 3D culture and assays and the main issues affecting quality and costs in this segment of the industry today. In addition, the workshop gives you the opportunity to exchange views with academic and industry peers who are active and interested in the field of 3D cell culture.

Date & Time: Monday 27 February 2012, 8.30 – 13.00
Venue: Arne Jacobsens Allé 15-17, 2300 Copenhagen S, Denmark
Room: Auditorium
Price:  Free of charge (late cancellation/no-show fee DKK 375)
Register
For MVA-members only. Please register below.
View if your organization is a member at www.mediconvalleyonline.com

In collaboration with:

Program

08.30-09.00Registration, networking and coffee
09.00-09.10Welcome
Thomas Mortensen, Development Manager, Medicon Valley Alliance
09.10-09.553D-cell-culture technologies, an overview
Dr. Simon Messner, Product Manager Toxicology, InSphero AG
09:55-10:25Microtissues in oncology
Tony Rutt, Sales and Business Development Manager, InSphero AG
10:25-10.45Coffee break
10:45-11:15Organotypic cell models in toxicology
Dr. Simon Messner, Product Manager Toxicology, InSphero AG
11:15-11:40Improved cell based models for pharma and biotech industry – combining viral vector and cell technology
Dr. Kathrin Schmitt, Director Key Accounts, SIRION BIOTECH GmbH
11:40-12:05Viral vectors and cellular models for drug research – from 2D to 3D
Dr. Christian Thirion, Chief Technology Officer, SIRION BIOTECH GmbH
12:05-12:153D Hands-on session
12:15-13:00Networking lunch

For further information, please contact:
InSphero AG – Manuela Vujevic, Marketing Manager at manuela.vujevic@insphero.com or +41 44 5150 490
Medicon Valley Alliance – Thomas Mortensen at thomas.mortensen@mva.org or +45 3287 8008

About InSphero
InSphero is the leading, award-winning supplier of assay-ready 3D microtissues for drug discovery and in vitro toxicology. We offer single and multicell microtissues off-the-shelf, 1 x microtissue per well in standard plate format, helping you to improve data relevance and to reduce the overall cost of drug discovery. The company is headquartered in Zurich, Switzerland, and has established a solid customer base with more than ten global pharmaceutical and cosmetics companies. Read more about InSphero here.